Insulin resistance in porphyria cutanea tarda
It has been reported that patients with porphyria cutanea tarda (PCT) develop carbohydrate (CHO) intolerance and manifest diabetes mellitus (DM) more frequently than the normal population. In order to verify whether this is due to insulin resistance we studied 5 patients with PCT and 5 normal subjects matched for age, sex and weight. In all the patients an evaluation consisted of the glycemic curve and insulin response to an iv glucose tolerance test (IVGTT: 0.33 g/kg) as well as of an evaluation of the circulating monocyte insulin receptors. Blood samples were drawn in the basal state to measure plasma levels of NEFA, glycerol, and intermediate metabolites. The patients with PCT showed normal glucose tolerance which was obtained, however, at the expense of the elevated insulin levels: therefore a condition of insulin resistance was demonstrated in these subjects. An involvement of the lipid metabolism, observed by the raised levels of plasma NEFA and glycerol, was also evident. The insulin binding to circulating monocytes was reduced but not enough to justify the degree of insulin resistance observed. Therefore, it could be hypothesized, in agreement with similar studies, that a postreceptor defect is responsible for the insulin-resistance observed in patients with PCT and that the reduction of insulin receptors is determined by the down regulation in response to elevated insulinemic levels. An alteration of the porphyrin metabolism might be responsible for this disorder.
Key-wordsInsulin resistance porphyria cutanea tarda insulin receptor intermediate metabolites IVGTT
Unable to display preview. Download preview PDF.
- 1.Harber L.C., Bickers D.R. The prophyrias: Basic science aspects, clinical diagnosis and management. In: Malkinson F., Pearson R. (Eds.), The Yearbook of Dermatology. Yearbook Medical Publishers Inc., Chicago, 1975, p. 9.Google Scholar
- 6.Walderstrom J, Haeger-Aronsen B. In: Steinberg A.G., Beams A.G. (Eds.), The porphyrias: A genetic problem. Progress in medical genetics ed. 5. Grune and Stratton, New York, 1967, 58.Google Scholar
- 7.Binazzi M., Calandra P., Lisi P., Tomassini M., Frillici S., Lattanzi M., Brunetti P., Bonelli M. Cute e diabete. Giorn. Min. Derm. 111: 427, 1976.Google Scholar
- 8.Binazzi M., Lisi P., Calandra P. Studies on the association between skin disorders and diabetes. Ann. It. Derm. Clin. Sper. 32: 211, 1978.Google Scholar
- 13.Von Kostler E. Porphyria cutanea tarda und Diabetes mellitus. Dermatol. Mon. Schr. 172: 481, 1986.Google Scholar
- 18.Boyum A. A one stage procedure for isolation of granulocytes and lymphocytes from human blood. Scand. J. Clin. Lab. Invest. 97: 21, 1968.Google Scholar
- 21.De Meyts P., Roth J. Cooperativity in ligand binding: A new graphic analysis. Biochem. Biophys. Res. Commun. 66: 1118, 1975.Google Scholar
- 25.De Fronzo R., Ferrannini E., Koivisto V. New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. Am. J. Med.: 52, 1983.Google Scholar
- 28.Calafiore R., Scionti L., Calcinaro F., Pietropaolo M., Basta G., Santeusanio F. Glucocorticoidi e resistenza insulinica: Effetti di desametasone, betametasone e triamcinolone sui recettori insulinici di soggetti normali. Rec. Progr. Med. 76: 22, 1985.Google Scholar
- 30.Trischitta V., Brunetti A., Benzi L., Marchetti P., Vigneri R. Characterization of insulin degrading activity in subcellular fractions of human monocytes. Diab.Nutr. Metab. 1: 71, 1988.Google Scholar
- 32.Dupré J., Lubetzki J., Warnet A. Etude de la tolerance au glucose, de I’insulino-secretion et de la sensibilité endogène au cours de affections alcooliques du fois. Le Diabéte 22: 143, 1974.Google Scholar